Center for Prevention Implementation Methodology for Drug Abuse and HIV (Ce-PIM)
- Funded by National Institutes of Health (NIH)
- Total publications:0 publications
Grant number: 3P30DA027828-10S1
Grant search
Key facts
Disease
COVID-19Start & end year
20112021Known Financial Commitments (USD)
$171,041Funder
National Institutes of Health (NIH)Principal Investigator
C Hendricks BrownResearch Location
United States of AmericaLead Research Institution
Northwestern University At ChicagoResearch Priority Alignment
N/A
Research Category
Secondary impacts of disease, response & control measures
Research Subcategory
Indirect health impacts
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)
Vulnerable Population
Drug usersOther
Occupations of Interest
Unspecified
Abstract
Abstract: This administrative supplement to the NIDA funded Center for PreventionImplementation Methodology for Drug Abuse and HIV is submitted to address theurgent crises in delivering evidence-based interventions for preventing the spread ofHIV and preventing opioid related deaths due to the policies and practices now beingundertaken in immediate response to the COVID-19 pandemic. Because there is suchlimited research to draw upon in this crisis, we need to rely on innovative modelingapproaches that build on Ce-PIM's existing work, as we expand to meet the newchallenges addressed by local governmental agencies and service delivery systems.We are partnering formally in this application with the Pinellas County Opioid TaskForce, which includes the county's Health Department, Human Services, OperationPAR and the University of South Florida. We will adapt two existing agent-basedmodels/ decision support tools to provide decision support to local governmental andsystem leaders on optimizing a set of interventions to reduce HIV spread and opioidrelated deaths in Pinellas County where these systems have been heavily impacted byCOVID-19. These models are built alongside the Task Force and emphasize theimpact on vulnerable populations, including the homeless, and on delivery ofmedications for opioid use disorder.